EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Learning from inborn errors of immunity and secondary immune deficiencies about vaccine immunogenicity, efficacy, and safety

Nicholas E Peters iD, Adrian M Shields iD, Sophie Hambleton iD, Alex G Richter

Clinical and Experimental Immunology · 21.01.2025 · 219 (1)

DOI: 10.1093/cei/uxaf059 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Clinical and Experimental Immunology, online erschienen am 02.09.2025. Verfasst von Nicholas E Peters und 3 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Immunology Service, Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK. Hauptthemen laut MEDLINE: Immunologic Deficiency Syndromes, COVID-19 Vaccines, COVID-19, SARS-CoV-2. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 117 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Since its discovery in the late 18th century, the role of vaccination in preventing death and disease has expanded across many infectious diseases and cancer. Key to our understanding of vaccine immunogenicity and efficacy is knowledge of the immune system itself. Inborn errors of immunity (IEI) represent a heterogeneous group of disorders characterized by impaired function of the immune system. Patients with IEI can have variable responses to vaccinations, depending on the nature and extent of the defect. Studies performed during the recent COVID-19 pandemic have brought unique insight into vaccine immunogenicity in individuals with IEI, knowledge that can be extended to the growing number of patients with secondary immunodeficiency arising from malignancy, organ transplantation, autoimmune conditions, and their treatments. In this review, we describe vaccine immunogenicity in IEI alongside their equivalent secondary immunodeficiencies and discuss what lessons can be learned about immunization strategies more broadly.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Immunologic Deficiency SyndromesCOVID-19 VaccinesCOVID-19SARS-CoV-2Immunogenicity, VaccineHumansVaccinationVaccine Efficacy

Stichwörter der Autor:innen

immunodeficiency diseasesinfectionvaccine

Substanzen

COVID-19 Vaccines

Autor:innen und Institutionen

  • Clinical Immunology Service, Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK.
  • Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK.

ORCID-Profile: Nicholas E Peters, Adrian M Shields, Sophie Hambleton

Zitieren

APA

Peters, N. E., Shields, A. M., Hambleton, S., & Richter, A. G. (2025). Learning from inborn errors of immunity and secondary immune deficiencies about vaccine immunogenicity, efficacy, and safety. Clinical and Experimental Immunology, 219(1). https://doi.org/10.1093/cei/uxaf059

Vancouver

Peters NE, Shields AM, Hambleton S, Richter AG. Learning from inborn errors of immunity and secondary immune deficiencies about vaccine immunogenicity, efficacy, and safety. Clinical and Experimental Immunology. 2025;219(1). doi:10.1093/cei/uxaf059

BibTeX
@article{Peters2025,
  author = {Peters, Nicholas E and Shields, Adrian M and Hambleton, Sophie and Richter, Alex G},
  title = {Learning from inborn errors of immunity and secondary immune deficiencies about vaccine immunogenicity, efficacy, and safety},
  journal = {Clinical and Experimental Immunology},
  year = {2025},
  volume = {219},
  number = {1},
  doi = {10.1093/cei/uxaf059}
}
Kostenlos starten →